Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1Holistic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback